178 related articles for article (PubMed ID: 19011743)
1. Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.
Gallien S; Fournier S; Porcher R; Bottero J; Ribaud P; Sulahian A; Socié G; Molina JM
Infection; 2008 Dec; 36(6):533-8. PubMed ID: 19011743
[TBL] [Abstract][Full Text] [Related]
2. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Lortholary O; Meyohas MC; Dupont B; Cadranel J; Salmon-Ceron D; Peyramond D; Simonin D
Am J Med; 1993 Aug; 95(2):177-87. PubMed ID: 8395142
[TBL] [Abstract][Full Text] [Related]
3. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature.
Iwen PC; Rupp ME; Langnas AN; Reed EC; Hinrichs SH
Clin Infect Dis; 1998 May; 26(5):1092-7. PubMed ID: 9597234
[TBL] [Abstract][Full Text] [Related]
4. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of 61 patients with pulmonary aspergilloma.
Kawamura S; Maesaki S; Tomono K; Tashiro T; Kohno S
Intern Med; 2000 Mar; 39(3):209-12. PubMed ID: 10772121
[TBL] [Abstract][Full Text] [Related]
6. [Case of pulmonary aspergillosis successfully treated with itraconazole].
Watanabe T; Kuriyama K; Kamei K
Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
[No Abstract] [Full Text] [Related]
7. Invasive aspergillosis in developing countries.
Chakrabarti A; Chatterjee SS; Das A; Shivaprakash MR
Med Mycol; 2011 Apr; 49 Suppl 1():S35-47. PubMed ID: 20718613
[TBL] [Abstract][Full Text] [Related]
8. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus.
Torres HA; Rivero GA; Lewis RE; Hachem R; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2003 May; 46(1):25-8. PubMed ID: 12742315
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases.
Wright JA; Bradfield SM; Park JR; Hawkins DS
J Pediatr Hematol Oncol; 2003 Apr; 25(4):286-91. PubMed ID: 12679641
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
van Vianen W; de Marie S; ten Kate MT; Mathot RA; Bakker-Woudenberg IA
J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
13. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
15. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
16. [Fever and cavitary infiltrate in a renal transplant recipient].
Rocamora N; Tormo AM; Franco A; Alvarez Avellán L; Olivares J
Nefrologia; 2004; 24 Suppl 3():16-20. PubMed ID: 15219062
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients.
Robinson LA; Reed EC; Galbraith TA; Alonso A; Moulton AL; Fleming WH
J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1182-96; discussion 1196-7. PubMed ID: 7776682
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
Anugulruengkitt S; Trinavarat P; Chantranuwat P; Sritippayawan S; Pancharoen C; Thanyawee P
J Med Assoc Thai; 2016 Feb; 99(2):150-8. PubMed ID: 27249894
[TBL] [Abstract][Full Text] [Related]
19. Standardization of an experimental murine model of invasive pulmonary aspergillosis.
Sheppard DC; Graybill JR; Najvar LK; Chiang LY; Doedt T; Kirkpatrick WR; Bocanegra R; Vallor AC; Patterson TF; Filler SG
Antimicrob Agents Chemother; 2006 Oct; 50(10):3501-3. PubMed ID: 17005844
[TBL] [Abstract][Full Text] [Related]
20. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
